AGX.NYSEArgan INC

Form 4: Argan Inc. Director James Quinn Exercises Options and Sells Shares in Significant Insider Transactions

Sentiment:

Insider Trading Report


Argan Inc. Director James W. Quinn engaged in substantial insider trading activity, exercising a large number of stock options and subsequently selling 40,000 shares of common stock on the open market.

Worse than expectedThe sale of 40,000 shares by a director, even after exercising options, can be interpreted by the market as a negative signal regarding future company prospects or a lack of confidence, potentially leading to downward pressure on the stock price.

Summary

  • James W. Quinn, a Director of Argan Inc. (AGX), executed multiple stock transactions on June 9 and 10, 2025.
  • On June 9, 2025, Mr. Quinn exercised various stock options, resulting in the acquisition of a net total of 55,757 shares of common stock at exercise prices ranging from $30.44 to $71.75 per share, primarily utilizing a net settlement method.
  • On June 10, 2025, an additional 390 shares of common stock vested from Time-Based Restricted Stock Units (TRSUs) at a price of $0.
  • Concurrently, on June 10, 2025, Mr. Quinn sold 40,000 shares of Argan Inc. common stock on the open market at an average price of $207.92 per share.
  • Following these transactions, Mr. Quinn's direct beneficial ownership in Argan Inc. stands at 16,557 shares, and his indirect beneficial ownership through the James W. Quinn 2025 GRAT No.1 is 63,014 shares, bringing his total beneficial ownership to 79,571 shares.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the significant insider selling, which can be perceived as a bearish signal by the market, despite the underlying option exercises.

Positives

  • The exercise of a large volume of stock options by a director indicates a belief in the underlying value of the company's stock at the time of exercise.
  • The sale of shares at an average price of $207.92, significantly higher than the option exercise prices, demonstrates substantial personal profit realization for the director.

Negatives

  • The sale of 40,000 shares by a director on the open market could be perceived negatively by investors, potentially signaling a lack of confidence or a strategic move to diversify holdings.

Risks

  • Significant insider selling, even if for personal financial planning, can sometimes lead to negative investor sentiment and put downward pressure on the stock price.

Future Outlook

NA

Industry Context

This Form 4 filing details routine insider transactions (option exercises and subsequent sales) by a director. Such filings are common and provide transparency into insider holdings and trading activity, which can sometimes influence market perception of a company's stock.

Related Party Transactions

  • The indirect beneficial ownership of 63,014 shares through 'the James W. Quinn 2025 GRAT No.1' represents a related party holding.

Stakeholder Impact

  • Shareholders: May interpret the director's sale as a signal, potentially influencing their investment decisions. The transparency of the filing provides insight into insider activity.
  • Employees: No direct impact mentioned, but significant insider selling could subtly affect morale if perceived negatively.

Key Dates

DateDescription
2016-01-07Award date for stock option exercised on June 9, 2025, to purchase 10,000 shares at $30.44.
2017-01-05Award date for stock option exercised on June 9, 2025, to purchase 10,000 shares at $71.75.
2018-01-11Award date for stock option exercised on June 9, 2025, to purchase 10,000 shares at $46.35.
2018-12-12Award date for stock option exercised on June 9, 2025, to purchase 10,000 shares at $41.19.
2019-12-23Award date for stock option exercised on June 9, 2025, to purchase 10,000 shares at $40.15.
2020-12-14Award date for stock option exercised on June 9, 2025, to purchase 10,000 shares at $45.75.
2021-12-14Award date for stock option exercised on June 9, 2025, to purchase 5,000 shares at $37.13.
2022-12-16Award date for stock option exercised on June 9, 2025, to purchase 3,334 shares at $35.72.
2023-12-14Award date for stock option exercised on June 9, 2025, to purchase 500 shares at $43.70.
2024-12-12Award date for Time-Based Restricted Stock Unit (TRSU) which vested on June 10, 2025.
2025-06-09Date of multiple stock option exercises by James W. Quinn.
2025-06-10Date of vesting of Time-Based Restricted Stock Units and open market sale of shares by James W. Quinn.
2025-06-11Signature date of the reporting person for the Form 4 filing.

Recommendation

hold

Keywords

Argan Inc., AGX, Insider Trading, Form 4, Stock Options, Share Sale, Director Transactions, Beneficial Ownership, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.